Conatus Pharmaceuticals Inc (HSTO)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

10655 SORRENTO VALLEY ROAD SAN DIEGO, CA 92121

Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Histogen's innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen's proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair.

Data as of 2021-07-25 17:03:18 -0400
Market Cap28.956 Million Shares Outstanding35.752 Million Avg 30-day Volume724.06 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.71171 52-week High/Low3.59 / 0.749 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from HSTO instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 28 22 27.27% 5 (0.29%) 7 (0.41%) -28.57%
13F shares: 1.677 Million 526.62 Thousand 218.37% 276.699 Thousand 189.476 Thousand 46.03%
% Ownership 46.9847 1.9775 2275.96% 7.7543 0.7115 989.85%
New Positions: 10 4 150.0% 1 3 -66.67%
Increased Positions 7 3 133.33% 2
Closed Positions 3 3 0.0% 2 1 100.0%
Reduced Positions 1 5 -80.0% 3
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding HSTO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HSTO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PASCOE RICHARD W PRESIDENT, CEO & DIRECTOR

  • Officer
  • Director
30,000 2021-03-30 3

FUHRMANN ROCHELLE

  • Director
0 2021-03-25 2

WINDHAM-BANNISTER SUSAN RICHARDS

  • Director
0 2021-03-10 2

NAUGHTON GAIL K SEE REMARKS

  • Officer
0 2021-01-13 1

LATTERICH MARTIN SVP, TECHNICAL OPERATIONS

  • Officer
0 2021-01-13 1

KNUDSON SUSAN A. EVP, CFO & CORP SECY

  • Officer
0 2021-01-13 1

DANIELS MOYA SEE REMARKS

  • Officer
0 2021-01-13 3

MENTO STEVEN J

  • Director
0 2020-10-07 1

KISNER DANIEL L

  • Director
0 2020-10-07 1

ZHANG YIZHUO

  • Director
0 2020-10-07 1

CHANG STEPHEN

  • Director
0 2020-10-07 1

CREAN DAVID HUGH

  • Director
0 2020-10-07 1

SATZ BRIAN

  • Director
0 2020-10-07 1

JACKSON JONATHAN

  • Director
  • 10% Owner
0 2020-10-07 1

SPADA ALFRED P. EVP, R&D AND CSO

  • Officer
No longer subject to file 2020-05-22 0

MARSHALL KEITH W EVP, COO & CFO

  • Officer
No longer subject to file 2020-05-22 0

SCOTT KATHLEEN D.

  • Director
0 2019-11-18 0

VANDERTIE MICHELLE L VICE PRESIDENT, FINANCE

  • Officer
0 2019-08-01 0

HALE DAVID F

  • Director
0 2019-06-27 0

VAN WART HAROLD

  • Director
0 2019-06-27 0

KLASSEN PRESTON

  • Director
0 2019-06-27 0

LARUE WILLIAM R

  • Director
0 2019-06-27 0

HAGERTY DAVID T EVP, CLINICAL DEVELOPMENT

  • Officer
0 2019-02-07 0

SMITH EDWARD F III SVP, REG AFFAIRS AND QA

  • Officer
10,875 2019-02-07 0

RIPLEY DANIEL L. SVP, BUS DEV, P&A MGMT

  • Officer
32,431 2019-02-07 0

SCOPA JAMES PAUL

  • Director
0 2018-06-21 0

CASHION CHARLES SVP, FINANCE, CFO AND SEC.

  • Officer
0 2017-01-26 0

MALIK SHAHZAD

  • Director
  • 10% Owner
0 2016-06-23 0

LACASSE LOUIS P

  • Director
0 2015-06-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
HISTOGEN INC HSTO 2021-07-28 18:15:03 UTC -2.3382 2.4182 1300000
HISTOGEN INC HSTO 2021-07-28 17:45:03 UTC -2.3382 2.4182 1300000
HISTOGEN INC HSTO 2021-07-28 17:15:03 UTC -2.3382 2.4182 1300000
HISTOGEN INC HSTO 2021-07-28 16:45:03 UTC -2.3301 2.4101 1300000
HISTOGEN INC HSTO 2021-07-28 16:15:02 UTC -2.3301 2.4101 1300000
HISTOGEN INC HSTO 2021-07-28 15:45:03 UTC -2.3301 2.4101 1300000
HISTOGEN INC HSTO 2021-07-28 15:15:03 UTC -2.3301 2.4101 1300000
HISTOGEN INC HSTO 2021-07-28 14:45:02 UTC -2.3731 2.4531 1300000
HISTOGEN INC HSTO 2021-07-28 14:15:03 UTC -2.3731 2.4531 1300000
HISTOGEN INC HSTO 2021-07-28 13:45:02 UTC -2.3731 2.4531 1300000
HISTOGEN INC HSTO 2021-07-28 13:15:03 UTC -2.3731 2.4531 1300000
HISTOGEN INC HSTO 2021-07-28 12:45:03 UTC -2.3731 2.4531 1300000
HISTOGEN INC HSTO 2021-07-27 22:15:03 UTC -2.3731 2.4531 1300000
HISTOGEN INC HSTO 2021-07-27 21:45:03 UTC -2.3315 2.4115 1300000
HISTOGEN INC HSTO 2021-07-27 21:15:03 UTC -2.3315 2.4115 1300000
HISTOGEN INC HSTO 2021-07-27 20:45:03 UTC -2.2776 2.3576 1300000
HISTOGEN INC HSTO 2021-07-27 20:15:03 UTC -2.2776 2.3576 1300000
HISTOGEN INC HSTO 2021-07-27 19:45:02 UTC -2.2776 2.3576 1300000
HISTOGEN INC HSTO 2021-07-27 19:15:02 UTC -2.2776 2.3576 1300000
HISTOGEN INC HSTO 2021-07-27 18:45:03 UTC -2.2776 2.3576 1300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund HSTO -3600.0 shares, $-4680.0 2021-03-31 N-PORT

Elevate your investments